The speakers from our January panel discussion on immunogenicity answer further questions from the live event
We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on FDA guidance, transitioning skills and future hopes for the bio lab.
Webinar available to view on demand. In this case study, Alturas Analytics (ID, USA) presents the techniques they use in their labs for optimal analysis of large molecules from biological matrices.
Thank you everyone who attended our live webinar ‘Clinical relevance of (unwanted drug induced) immune responses’. Here are some responses to the questions posed during the live event that we did not have time to answer.
Webinar available to view on demand. In this free panel discussion, our experts will provide insights into their own research with immunogenicity including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Webinar available to view on demand. This webinar will give an overview of immunogenicity assay development, explore the impact of anti-drug antibodies on bioanalysis and review relevant case studies discussing in-study cut-point and tolerance.
Webinar available to view on demand. Learn how a standardized approach for the bioanalysis of biotherapeutics by hybrid LC–MS is applied in a contract research environment, whilst also considering compliance with regulatory requirements.
Webinar available to view on demand. Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant?
Electron paramagnetic resonance has been used to measure in-cell distances between spin labels with higher sensitivity than previously seen for conversional methods.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
In this installment of Robert MacNeill’s (Envigo) column, Robert discusses methodologies for small lipids, and why these can be a particularly challenging area of biologics.